Causes
Mucormycosis is caused by exposure to mucormycetes, a group of molds that are common in the environment. These fungi are found in soil, leaves, compost, and decaying organic matter. Most people come into contact with these spores every day without getting sick because their immune systems can fight them off. The infection occurs when the spores enter the body through inhalation, direct skin contact with a cut or burn, or ingestion, and the immune system is unable to prevent the fungus from growing and invading tissues.

Risk Factors
Certain medical conditions and treatments significantly increase the risk of developing this infection by weakening the immune system or creating a favorable environment for the fungus to grow. Known risk factors include:

• Uncontrolled diabetes, particularly in people with diabetic ketoacidosis (a condition with high blood acid levels).
• Cancer, especially blood cancers like leukemia and lymphoma.
• Organ or stem cell transplantation.
• Low white blood cell counts (neutropenia).
• Long-term use of corticosteroids.
• Iron overload in the body (hemochromatosis) or therapy with specific iron-chelating drugs.
• Skin injuries such as burns, surgical wounds, or cuts that are exposed to soil.
• Severe COVID-19 infection, particularly when treated with systemic steroids.
• Prematurity and low birth weight in infants (often associated with gastrointestinal infection).

Prevention
Because the fungi that cause mucormycosis are widespread in the environment, it is difficult to completely avoid exposure. For people with weakened immune systems or high-risk conditions, primary prevention focuses on reducing exposure to the mold. Strategies include avoiding areas with a lot of dust like construction or excavation sites, staying away from water-damaged buildings, and avoiding close contact with soil or manure. If being in these environments is unavoidable, wearing an N95 respirator mask may offer some protection. Reducing the severity of underlying conditions, such as maintaining good blood sugar control in people with diabetes and using steroids only as prescribed, is also a critical preventive measure. Secondary prevention involves keeping skin injuries clean and covered to prevent fungal entry.

Signs and Symptoms
Symptoms of mucormycosis depend on where the infection is located in the body. The condition typically progresses rapidly.

• Rhinocerebral (Sinus and Brain): This is the most common form and often presents with one-sided facial swelling, headache, nasal or sinus congestion, and fever. A distinct sign is black lesions on the bridge of the nose or the inside of the mouth that quickly become more severe. Patients may also experience eye pain, loss of vision, or blurred vision.
• Pulmonary (Lung): Symptoms include fever, cough, chest pain, and shortness of breath. It can be difficult to distinguish from other lung infections without testing.
• Cutaneous (Skin): The infected area may look like a blister or ulcer, and the infected tissue often turns black. The area may become warm, red, painful, and swollen.
• Gastrointestinal (Gut): This form is more common in young children and includes abdominal pain, nausea, vomiting, and gastrointestinal bleeding (blood in the stool).
• Disseminated: This occurs when the infection spreads through the bloodstream to other parts of the body, such as the brain, spleen, heart, or skin. Symptoms depend on the specific organ affected.

Diagnosis
Early diagnosis is critical for survival. Clinicians typically use a combination of physical exams, imaging tests, and laboratory work. A biopsy is usually the most important tool; a small sample of affected tissue is removed and examined under a microscope to look for the characteristic wide, ribbon-like appearance of the fungus. The tissue may also be cultured in a lab to confirm the specific type of fungus. Imaging tests like CT scans or MRIs of the lungs, sinuses, or facial structures are used to determine the extent of the infection and tissue damage. Blood tests are generally not useful for diagnosing mucormycosis directly, although they help assess underlying risk factors like blood sugar levels.

Medical and Surgical Treatment
Treatment for mucormycosis must be aggressive and immediate. It typically involves a combination of antifungal medication and surgery.

• Antifungal Medications: Intravenous (IV) antifungal drugs, such as amphotericin B, posaconazole, or isavuconazole, are the standard treatment. These medications are often required for several weeks or months.
• Surgery: Because the infection causes tissue death and reduced blood flow, antifungal medicines often cannot reach the infected area effectively. Therefore, surgical removal (debridement) of the dead and infected tissue is frequently necessary. In severe cases, this may involve removing parts of the nose, eyes, or palate to stop the infection from spreading to the brain.
• Managing Underlying Conditions: Controlling the risk factors is an essential part of management. This includes correcting high blood sugar and acid levels in patients with diabetes, reducing or stopping immunosuppressive medications when possible, and managing iron levels.

When to Seek Medical Care
Mucormycosis is a medical emergency. You should seek immediate emergency care if you have a weakened immune system or diabetes and experience:

• Sudden vision changes, such as double vision or blindness.
• Swelling on one side of the face.
• Black crusts or scabs in the nose or mouth.
• Severe headache or sinus pain that does not improve.
• High fever with a cough or shortness of breath.

Severity and Disease Course
Mucormycosis is a very severe infection with a rapid disease course. It is classified as an invasive fungal infection, meaning it aggressively attacks tissues and blood vessels. Without treatment, the infection can be fatal within days to weeks. The disease does not typically go into remission on its own; it requires intensive medical and surgical intervention. The course of the disease depends heavily on the site of infection and the patient's underlying health.

Complications and Long-Term Effects
Survivors often face significant long-term challenges due to the destructive nature of the infection and the surgery required to treat it. Complications may include:

• Physical Disfigurement: Removal of tissue from the face, nose, or mouth can lead to permanent changes in appearance and function, often requiring reconstructive surgery or prosthetics.
• Sensory Loss: Loss of vision or even loss of an eye is a possible outcome of rhinocerebral mucormycosis.
• Organ Damage: Pulmonary or disseminated mucormycosis can lead to permanent lung scarring or damage to other organs like the kidneys.
• Neurological Deficits: If the infection reaches the brain, it can cause long-term cognitive or motor impairments.

Prognosis
The prognosis varies depending on the type of infection and how quickly treatment begins. Rhinocerebral mucormycosis generally has a better survival rate than pulmonary or disseminated forms if caught early, but the overall mortality rate remains high, often cited between 40% and 80% in various studies depending on the site of infection and patient factors. Early diagnosis, reversal of underlying risk factors (like correcting diabetic ketoacidosis), and aggressive surgical cleaning of the wound are the strongest predictors of survival.

Impact on Daily Activities and Coping
Recovering from mucormycosis is a long and often difficult process. Patients may spend weeks or months in the hospital receiving intravenous medications that can have side effects like kidney strain or nausea. Following discharge, daily life may be impacted by the need for ongoing oral medications and follow-up surgeries. For those who underwent extensive surgery, adapting to physical changes—such as the loss of an eye or changes to the facial structure—can be emotionally and socially challenging. Rehabilitation, including speech therapy or occupational therapy, may be needed to regain function. Support groups and mental health counseling are vital resources for coping with the trauma of a life-threatening illness and body image changes.

Questions to Ask Your Healthcare Provider
Asking the right questions can help you understand your path to recovery. Consider asking:

• What is the specific type of mucormycosis I have, and what organs are affected?
• Will I need surgery, and if so, how extensive will it be?
• What are the side effects of the antifungal medications I am taking?
• How can I best manage my underlying condition (like diabetes) to prevent the infection from returning?
• Are there reconstructive options available for the tissue that was removed?
• What signs of recurrence should I look for after I leave the hospital?

Q: Is mucormycosis contagious?
A: No, mucormycosis is not contagious. It does not spread from person to person or from animals to people. You can only get it from environmental spores.

Q: Why is it sometimes called "black fungus"?
A: It is often called black fungus because the infection causes the affected skin or tissue to die and turn black (necrosis), not because the fungus itself is black.

Q: Can healthy people get mucormycosis?
A: It is extremely rare for healthy people with normal immune systems to get this infection. It almost exclusively affects those with compromised immune systems or significant tissue trauma.

Q: Is there a vaccine for mucormycosis?
A: Currently, there is no vaccine available to prevent mucormycosis. Prevention relies on avoiding spores and managing risk factors.

Q: How long does treatment take?
A: Treatment duration varies but is typically long-term. Patients often need intravenous antifungal drugs for weeks, followed by oral medication for several months until the infection is completely cleared.